title: Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease.
abstract: Lipoprotein (a) [Lp(a)] is composed of 1 low-density lipoprotein (LDL) particle, to which 1 molecule of apolipoprotein (a) is covalently linked. Elevated levels of Lp(a) have been associated with coronary artery disease (CAD) and Lp(a) has been shown to be highly heritable. Our purpose was to determine the prevalence of familial Lp(a) excess in patients with CAD. We determined plasma levels of Lp(a) in 180 patients (150 men and 30 women) with angiographically documented CAD before age 60 years, and in 459 control subjects (276 men and 183 women) clinically free of cardiovascular disease. In addition, Lp(a) levels were determined in families of 102 of the CAD probands (87 men and 15 women). No gender differences in Lp(a) levels were observed between men and women (patients or control subjects). Patients with CAD had higher Lp(a) levels than did control subjects (19 +/- 21 vs 13 +/- 15 mg/dl, p less than 0.001). The prevalence of Lp(a) excess (defined as greater than 90th percentile of controls) was 17% in patients with CAD (p less than 0.05). Lp(a) levels were not correlated with cholesterol, LDL cholesterol, high-density lipoprotein (HDL) cholesterol or apolipoproteins A-I or B. There was a weak correlation between Lp(a) and triglycerides (r = 0.166, p less than 0.05) in patients and control subjects. Stepwise discriminant analysis revealed that Lp(a) was a risk factor for the presence of CAD in men, independent of smoking, hypertension, diabetes, LDL and HDL cholesterol, or apolipoprotein A-I and B levels. Family studies revealed that Lp(a) levels are strongly genetically determined.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Lipid Metabolism Laboratory, U.S.D.A. Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111.
authors.forename: J
authors.initials: J
authors.lastname: Genest
authors.forename: J L
authors.initials: JL
authors.lastname: Jenner
authors.forename: J R
authors.initials: JR
authors.lastname: McNamara
authors.forename: J M
authors.initials: JM
authors.lastname: Ordovas
authors.forename: S R
authors.initials: SR
authors.lastname: Silberman
authors.forename: P W
authors.initials: PW
authors.lastname: Wilson
authors.forename: E J
authors.initials: EJ
authors.lastname: Schaefer
mesh_terms: D001053:Apolipoproteins / Q000097:blood; D001900:Boston / Q000453:epidemiology; D003327:Coronary Disease / Q000097:blood* / Q000453:epidemiology / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D015995:Prevalence
chemical_list: D001053:Apolipoproteins; D017270:Lipoprotein(a); D008074:Lipoproteins